fr 139317 has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, HI; Hsieh, NK; Liu, DD; Yang, YL | 1 |
| Bratz, IN; Damron, DS; Guarini, G; Haney, RM; Meszaros, JG; Ohanyan, VA; Raman, P; Talasila, PK; Thodeti, CK | 1 |
| Ishiye, M; Kosuge, K; Nakashima, M; Umemura, K | 1 |
| Hamada, K; Nirei, H; Notsu, Y; Ono, T; Shoubo, M; Sogabe, K | 1 |
| Fujita, K; Matsumura, Y; Miyazaki, Y; Morimoto, S; Takaoka, M | 2 |
| Aarhus, LL; Burnett, JC; Clavell, AL; Heublein, DM; Mattingly, MT; Nir, A; Stevens, TL; Wright, S | 1 |
| Ando, T; Fujishima, M; Fukuda, K; Okuda, S; Tamaki, K; Yanagida, T | 1 |
| Burke, SE; Nelson, RA | 1 |
10 other study(ies) available for fr 139317 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats.
Topics: Animals; Azepines; Blood Urea Nitrogen; Collagen; Creatinine; Cyclic GMP; Disease Models, Animal; Endothelin-1; Enzyme Inhibitors; Gelatinases; Glomerular Filtration Rate; Hypertension; Indoles; Kidney; Matrix Metalloproteinases; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Tissue Inhibitor of Metalloproteinase-2 | 2008 |
Endothelin-mediated in vivo pressor responses following TRPV1 activation.
Topics: Adrenergic alpha-Agonists; Analysis of Variance; Animals; Azepines; Biphenyl Compounds; Blood Pressure; Capsaicin; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Femoral Artery; Indoles; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylephrine; Receptor, Endothelin A; Receptor, Endothelin B; TRPV Cation Channels; Vasoconstriction; Vasoconstrictor Agents | 2011 |
Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model.
Topics: Animals; Azepines; Blood Platelets; Brain; Cell Adhesion; Cerebral Arterial Diseases; Cerebral Infarction; Cerebrovascular Circulation; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Indoles; Intracranial Embolism and Thrombosis; Male; Radioimmunoassay; Rats; Rats, Wistar; Tissue Plasminogen Activator | 1995 |
An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs.
Topics: Animals; Azepines; Basilar Artery; Blood Pressure; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Heart Rate; Indoles; Ischemic Attack, Transient; Male; Radiography; Subarachnoid Hemorrhage | 1993 |
Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
Topics: Administration, Oral; Analysis of Variance; Animals; Arginine; Azepines; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Hypertension; Indoles; Injections, Intravenous; Kidney; Male; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A | 1995 |
Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Disease Models, Animal; Dogs; Endothelins; Heart Failure; Hemodynamics; Indoles; Male; Vena Cava, Inferior | 1996 |
Role of endothelin as a mitogen in experimental glomerulonephritis in rats.
Topics: Animals; Azepines; Base Sequence; Cell Division; Disease Models, Animal; DNA Primers; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; In Situ Hybridization; Indoles; Macrophages; Male; Mitogens; Molecular Sequence Data; Monocytes; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger | 1996 |
Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Azepines; Blood Pressure; Cardiomegaly; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Hypertension; Indoles; Male; Mesenteric Arteries; Rats; Rats, Sprague-Dawley | 1996 |
Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion.
Topics: Animals; Azepines; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Heart; Indoles; Male; Myocardial Infarction; Rabbits; Time Factors | 1997 |